Zhida Y. Liu

State Key Laboratory Of Natural Medicines
Nanjing, 211198, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Supramolecular Recognition-Based Hydrogels Incorporating Vascular Endothelial Growth Factor and Hesperadin for Infarcted Myocardial Repair and Angiogenesis.

Supramolecular Recognition-Based Hydrogels Incorporating Vascular Endothelial Growth Factor and Hesperadin for Infarcted Myocardial Repair and Angiogenesis.

Journal: Acta biomaterialia
Published: January 23, 2026

Synchronized Latency Reversal and Immune Clearance by a Multifunctional Fusion Protein Enables HIV-1 Reservoir Reduction.

Synchronized Latency Reversal and Immune Clearance by a Multifunctional Fusion Protein Enables HIV-1 Reservoir Reduction.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 15, 2025

Development of a Cellular Membrane Nanovesicle-Based Vaccine Against Porcine Epidemic Diarrhea Virus.

Development of a Cellular Membrane Nanovesicle-Based Vaccine Against Porcine Epidemic Diarrhea Virus.

Journal: Cells
Published: November 22, 2025

Corrigendum to "Dynamically assembled nanomedicine based on host-guest molecular recognition for NIR laser-excited chemotherapy and phototheranostics" [Acta Biomaterilia. Volume 168, 15 September 2023, Pages 565-579].

Corrigendum to "Dynamically assembled nanomedicine based on host-guest molecular recognition for NIR laser-excited chemotherapy and phototheranostics" [Acta Biomaterilia. Volume 168, 15 September 2023, Pages 565-579].

Journal: Acta biomaterialia
Published: October 23, 2025

A tripartite therapeutic agent reprograms the myocardial infarction microenvironment.

A tripartite therapeutic agent reprograms the myocardial infarction microenvironment.

Journal: Materials today. Bio
Published: June 28, 2025

Split intron-exon system for circular RNA synthesis.

Split intron-exon system for circular RNA synthesis.

Journal: Nature communications
Published: May 10, 2025

Development of a trispecific fusion protein based on angiotensin-converting enzyme 2, glycoprotein 130, and tumor necrosis factor receptor 2 as a promising therapeutic for COVID-19.

Development of a trispecific fusion protein based on angiotensin-converting enzyme 2, glycoprotein 130, and tumor necrosis factor receptor 2 as a promising therapeutic for COVID-19.

Journal: Molecular biomedicine
Published: April 20, 2025

Coordinating interleukin-2 encoding circRNA with immunomodulatory lipid nanoparticles to potentiate cancer immunotherapy.

Coordinating interleukin-2 encoding circRNA with immunomodulatory lipid nanoparticles to potentiate cancer immunotherapy.

Journal: Science advances
Published: February 26, 2025

Comparison between compositional data analysis and principal component analysis for identifying dietary patterns associated with hyperuricemia.

Comparison between compositional data analysis and principal component analysis for identifying dietary patterns associated with hyperuricemia.

Journal: Frontiers in nutrition
Published: February 26, 2025

Catalytic Hybrid Lipid Nanoparticles Potentiate Circle RNA-Based Cytokine Immunotherapy.

Catalytic Hybrid Lipid Nanoparticles Potentiate Circle RNA-Based Cytokine Immunotherapy.

Journal: ACS nano
Published: February 20, 2025

CircRNA vaccine encoding a chimeric immunogen of B6 and M1 demonstrates robust immune responses against MPXV.

CircRNA vaccine encoding a chimeric immunogen of B6 and M1 demonstrates robust immune responses against MPXV.

Journal: Cell reports
Published: January 30, 2025

Bivalent circular RNA vaccines against porcine epidemic diarrhea virus and transmissible gastroenteritis virus.

Bivalent circular RNA vaccines against porcine epidemic diarrhea virus and transmissible gastroenteritis virus.

Journal: Frontiers in immunology
Published: January 18, 2025
Showing 1-12 of 25

Last Updated: 09/26/2026